Skip to main content
. 2024 Dec 19;19(1):e12058. doi: 10.1002/ccs3.12058

FIGURE 4.

FIGURE 4

ANXA114‐26 may affect the proliferation and drug resistance of ovarian cancer cells through the Cyclin D1 and NF‐ĸBp65 signaling pathways. (A) Differences in mRNA expression of Cyclin D1 between SKOV3 and SKOV3/DDP cell lines. (B) Differences in mRNA expression of NF‐ĸBp65 between SKOV3 and SKOV3/DDP cell lines. (C) Differences in protein expression of Cyclin D1 and NF‐ĸBp65 between SKOV3 and SKOV3/DDP cell lines. (D) The relative expression of Cyclin D1 mRNA. (E) The relative expression of NF‐ĸBp65 mRNA. (F) Protein expression levels of Cyclin D1 and NF‐ĸBp65. (G) The relative expression of Cyclin D1 mRNA. (H) The relative expression of NF‐ĸBp65 mRNA. (I) Protein expression levels of Cyclin D1 and NF‐ĸBp65. The data were independently replicated in triplicate., *p < 0.05, **p < 0.01.